Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Donna J. Fournier is active.

Publication


Featured researches published by Donna J. Fournier.


Experimental Biology and Medicine | 1971

Variations in ATPase activity in the development of experimental cataracts.

Donna J. Fournier; John W. Patterson

Summary Determinations of Mg ATPase and Na/K ATPase activity in lens epithelium and in decapsulated lenses or lens fibers were made in lenses obtained from rats on normal and galactose diets at 0, 6, 15, and 23 days of the experimental period. Galactose feeding resulted in a marked lowering of Mg ATPase activity in the epithelium after 6 days on the diet. The level of Na/K ATPase activity was markedly decreased in the fibers after 15 days on the diet. The lowering of Na/K ATPase activities in the fibers may provide a possible link between the known decrease in the glutathione early in the cataractogenic process and the known destruction of fiber membranes that is associated with the appearance of mature cataracts.


Drug Metabolism Reviews | 1988

A Gompertz Age-Specific Mortality Rate Model of Aging, Hormesis, and Toxicity: Fixed-Dose Studies

Patricia J. Neafsey; Harold Boxenbaum; Domenic A. Ciraulo; Donna J. Fournier

Based on the proposition that the logarithm of age-specific mortality rate (Gompertzian) is a linear measure of the mean intensity of injury for a homogeneous mammalian population in a uniform environment, a model was developed which characterizes mortality experience resulting from both toxic and hormetic actions. The mortality-reducing component (longevity hormesis) was assumed to be reversible; toxic effects, on the other hand, were assumed to accumulate irreversibly. Following chronic low-dose administration of selected toxic substances, it was demonstrated (in certain cases) that longevity hormesis could enhance lifespan, even in the presence of concomitant toxicity. Even when toxicity was evident, hormesis could ameliorate some of the mortality. The assumption that high-dose chronic toxicity studies can generate realistic estimates of risk at low doses is challenged.


Drug Metabolism Reviews | 1989

A Gompertz age-specific mortality rate model of aging: modification by dietary restriction in rats

Patricia J. Neafsey; Harold Boxenbaum; Domenic A. Ciraulo; Donna J. Fournier

A Gompertz age-specific mortality rate model characterizing actuarial effects of food restriction in rats was developed based on mortality data from the study of Yu et al. (J. Gerontol. 40: 657-670, 1985). Results indicated that in the presence of adequate nutrition, food restriction reduces the aging rate parameter in a consistent manner, regardless of the age at which food restriction is initiated.


Experimental Biology and Medicine | 1970

Lens regeneration after mature galactose cataract formation.

Donna J. Fournier; John W. Patterson

Summary Following the development of mature cataracts in the lenses of rats, one group of rats was placed on a normal diet and a control group continued on the galactose diet. New healthy lens fibers were formed around a dense opaque nucleus in the lenses of rats on the normal diet. Those that were continued on a galactose diet had lenses that were completely opaque. The implication of this observation for further experimental studies and for the interpretation of the etiology of cataractogenesis is discussed.


European Journal of Pharmacology | 1982

Inhibition of [3H]5-HT binding to rat brain membranes by psychotomimetic amphetamines

Adrie P. De Jong; Florence Huggins; Donna J. Fournier; Alexandros Makriyannis

A number of psychotomimetric amphetamines have been tested for their ability to inhibit specific [3H]5-HT binding to rat brain membranes. Although the compounds studied showed only weak affinities for the specific [3H]5-HT sites, their IC50 values correlated roughly with their rank order in human hallucinigenic potency.


European Journal of Pharmacology | 1982

Structure activity correlations in the inhibition of brain synaptosomal3H-norepinephrine uptake by phenethylamine analogs. The role of α-alkyl side chain and methoxyl ring substitutions

Alexandros Makriyannis; Don Bowerman; Paul Y. Sze; Donna J. Fournier; Adrie P. De Jong

alpha-Ethylphenethylamine proved to be a weaker inhibitor of rat brain synaptosomal [3H]norepinephrine ([3H]NE) uptake than amphetamine, while 2-amino-tetralin and 2-amino-1,2-dihydronaphtalene, compounds in which the alpha-side chain ethyl group is tied to the aromatic ring have a similar inhibiting potency as amphetamine. Hallucinogenic polymethoxy substituted phenethylamine analogs have very low inhibitory potencies indicating that inhibition of NE-reuptake in brain noradrenergic neurons is not associated with the drug-induced hallucinogenic syndrome.


Molecular Pharmacology | 2005

(-)-7′-Isothiocyanato-11-hydroxy-1′,1′-dimethylheptylhexahydrocannabinol (AM841), a High-Affinity Electrophilic Ligand, Interacts Covalently with a Cysteine in Helix Six and Activates the CB1 Cannabinoid Receptor

Robert P. Picone; Atmaram D. Khanolkar; Wei Xu; Lionel A. Ayotte; Ganesh A. Thakur; Dow P. Hurst; Mary E. Abood; Patricia H. Reggio; Donna J. Fournier; Alexandros Makriyannis


Drug Metabolism Reviews | 1988

Hormesis, gompertz functions, and risk assessment

Harold Boxenbaum; Patricia J. Neafsey; Donna J. Fournier


Archive | 1992

Phospholipid compounds and use therefor

Alexandros Makriyannis; Richard I. Duclos; Donna J. Fournier


Journal of Peptide Research | 2002

Ligand based structural studies of the CB1 cannabinoid receptor

Robert P. Picone; Donna J. Fournier; Alexandros Makriyannis

Collaboration


Dive into the Donna J. Fournier's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kelley L. Morse

University of Connecticut

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Xiuyan Li

University of Connecticut

View shared research outputs
Researchain Logo
Decentralizing Knowledge